Lefèvre J P, Schröder R, Kowalski A. "一种来迪派韦杂质22的合成方法" [P]. European Patent, EP 3251772 A1, 2024-01-16.
发明人沈红梅,刘建华,赵玉洁. "Method for the Synthesis of Ledipasvir Impurity 22" [P]. 中国发明专利, 专利号 CN 111769200 A, 授权公告日 2019-01-16.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 来迪派韦杂质22 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2016, 1415, (7), 8578-8599.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 来迪派韦杂质22 as an Impurity". Molecules, 2024, 1204, 2233-2237.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Ledipasvir Impurity 22 Using HRMS and NMR". Food Chem., 2017, 2322, (8), 5122-5129.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 来迪派韦杂质22 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2012, 2373, (12), 5975-5995.